Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing all-trans retinoic acid plus dexamethasone versus high-dose dexamethasone for initial treatment of primary immune thrombocytopenia has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Shandong University | Conditions: Purpura, Idiopathic Thrombocytopenic Purpura | Phase 3 | Status: WITHDRAWN